Impact Factor 2024

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients

S. Canestri, M.C. Totaro, E. Serone, B. Tolusso, D. Frezza, E. Gremese, G. Ferraccioli

368-373

20-12-2012

https://doi.org/10.4081/reumatismo.2012.368

2186

PDF: 822
Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a single center

S. Casigliani Rabl, A. Della Rossa, P. Pepe, A. D'Ascanio, M. Mosca, A. Di Vita, S. Bombardieri

158-165

19-07-2012

https://doi.org/10.4081/reumatismo.2012.158

1066

PDF: 857
Association between red cell distribution width and response to methotrexate in rheumatoid arthritis

M. Bellan, D. Soddu, E. Zecca, A. Croce, R. Bonometti, R. Pedrazzoli, D. Sola, C. Rigamonti, L.M. Castello, G.C. Avanzi, M. Pirisi, P.P. Sainaghi

16-20

10-04-2020

https://doi.org/10.4081/reumatismo.2020.1243

1567

PDF: 754
Psoriatic arthritis. When the heterogeneity requires normality

L. Punzi, R. Ramonda

59-65

05-06-2012

https://doi.org/10.4081/reumatismo.2012.59

868

PDF: 715
Biomarkers and prognostic stratification in psoriatic arthritis

L. Bogliolo, G. Crepaldi, R. Caporali

88-98

05-06-2012

https://doi.org/10.4081/reumatismo.2012.88

1450

PDF: 1316
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis

L. Quartuccio, S. Salvin, M. Saracco, S. Lombardi, M. Fabris, E. Mansutti, M. Maset, S. Pellerito, S. De Vita

182-186

https://doi.org/10.4081/reumatismo.2009.182

1021

PDF: 731
Familial Mediterranean fever without cardinal symptoms and role of genetic screening

T. Ulas, H. Buyukhatipoglu, C. Bes, M.S. Dal, I. Hacıbekiroglu, H.G. Apucu, F. Borlu

172-174

19-07-2012

https://doi.org/10.4081/reumatismo.2012.172

783

PDF: 806
Polarization of TH2 response is decreased during pregnancy in systemic lupus erythematosus

L. Iaccarino, A. Ghirardello, M. Zen, D. Villalta, A. Tincani, L. Punzi, A. Doria

314-320

11-12-2012

https://doi.org/10.4081/reumatismo.2012.314

2483

PDF: 1266
Influenza vaccination is safe and effective in patients suffering from fibromyalgia syndrome

J. N. Ablin, V. Aloush, A. Brill, M. Berman, M. Barzilai, D. Caspi, M. Mandelboim, D. Levartovsky, A. Polachek, Y. Wolman, D. Paran, M. Barkagan, O. Elkayam

57-61

16-09-2015

https://doi.org/10.4081/reumatismo.2015.823

2179

PDF: 1046
Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study

L. Bazzichi, D. Biasi, E. Tinazzi, M. Muratore, R. Pellerito, R. Russo, M. Corsaro Santi, P. De Sandre, O. Epis, M. Granata, B. Kroegler, C. Meschini, F. Versace, C. Astolfi

224-232

06-11-2014

https://doi.org/10.4081/reumatismo.2014.748

2325

PDF: 1575
Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis

C. Botsios, P. Sfriso, A. Furlan, P. Ostuni, M. Biscaro, U. Fiocco, S. Todesco, L. Punzi

32-37

https://doi.org/10.4081/reumatismo.2007.32

1664

PDF: 770
Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study

R. Talotta, A. Berzi, F. Atzeni, D. Dell'Acqua, P. Sarzi Puttini, D. Trabattoni

83-89

09-09-2016

https://doi.org/10.4081/reumatismo.2016.875

1864

PDF: 930

IL RUOLO DEI LINFOCITI TH9 NELL'ARTRITE REUMATOIDE E NELLA RISPOSTA AL TRATTAMENTO CON INFLIXIMAB.: 536
Osteoarthritis and osteoporosis: correlations between two clinical entities

I. Bertoldi, B. Frediani

51-54

27-05-2013

https://doi.org/10.4081/reumatismo.2013.51

2558

PDF: 913
Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis

Ş. Kobak, A. Berdeli

374-379

20-12-2012

https://doi.org/10.4081/reumatismo.2012.374

2216

PDF: 1195
Anti-dsDNA negative and anti-Ro positive lupus nephritis: a report of a rare case

D. Jain, H.K. Aggarwal, V. Kaverappa, S. Dhayia, P. Jain, S. Yadav

302-306

17-03-2014

https://doi.org/10.4081/reumatismo.2013.706

4789

PDF: 1323
CLINICAL OUTCOME MEASURES OF PSORIASIS

C. Bonifati, E. Berardesca

64-67

https://doi.org/10.4081/reumatismo.2007.1s.64

1012

PDF: 3057
Biologic therapy with anti-TNFa in rheumathoid atrhritis

G. Ferraccioli

17-21

https://doi.org/10.4081/reumatismo.2005.4s.17

759

PDF: 684
Contribution of the new 2012 EULAR/ACR classification criteria for the diagnosis of polymyalgia rheumatica

F. Muratore, C. Salvarani, P. Macchioni

18-22

27-03-2018

https://doi.org/10.4081/reumatismo.2018.1107

2990

PDF: 1674
Efficacy of gluten-free diet in patients with rheumatoid arthritis

V. Bruzzese, P. Scolieri, J. Pepe

213-217

18-01-2021

https://doi.org/10.4081/reumatismo.2020.1296

10613

PDF: 4274
Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity

A. Alunno, G. Nocentini, O. Bistoni, M.G. Petrillo, E. Bartoloni Bocci, S. Ronchetti, E. Lo Vaglio, C. Riccardi, R. Gerli

293-298

11-12-2012

https://doi.org/10.4081/reumatismo.2012.293

2571

PDF: 1006
Helicobacter pylori eradication induce platelet recovery in idiopathic thrombocytopenic purpura

G. Emilia, G. Longo, M. Luppi, G. Gandini, M. Morselli, L. Ferrara, S. Amarri, K. Cagossi, G. Torelli

330

https://doi.org/10.4081/reumatismo.2001.330

633

PDF: 499
Role for familiarity and genetic features in the therapeutic response of psoriatic arthritis

E. Taccari, A. Spadaro, M.L. Sorgi, V. Riccieri, B. Mora

162-168

https://doi.org/10.4081/reumatismo.2004.162

2590

PDF: 19108
A comparison between the Simplified Disease Activity Index (SDAI) and the Disease Activity Score (DAS28) as measure of response to treatment in patients undergoing different therapeutic regimens

Giovanna Cuomo, Gabriella Molinaro, Giovanni La Montagna, Sergio Migliaresi, Gabriele Valentini

22-25

https://doi.org/10.4081/reumatismo.2006.22

1538

PDF: 2018
The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature

S. Barsotti, E. Cioffi, A. Tripoli, A. Tavoni, A. d’Ascanio, M. Mosca, R. Neri

78-84

06-07-2018

https://doi.org/10.4081/reumatismo.2018.1011

2573

PDF: 1361
Response to: myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related

H. Quiñones-Moya, A. Camargo-Coronel, M.R. Hernández-Zavala

18-09-2023

https://doi.org/10.4081/reumatismo.2023.1623

901

PDF: 300
The role of leukemia inhibitory factor in autoimmune disorders: insights into recovery and treatment

Zahra Rodgarpoor, Ahmad Meshkin, Mohammadamin Ehramianpour, Fateme Zare

01-04-2025

https://doi.org/10.4081/reumatismo.2025.1753

1210

PDF: 374
Insight into the WNT system and its drug related response

S. Tamanini, L. Idolazzi, D. Gatti, O. Viapiana, A. Fassio, M. Rossini

219-230

18-12-2013

https://doi.org/10.4081/reumatismo.2013.219

3127

PDF: 1137
LABORATORY FINDINGS IN PSORIATIC ARTHRITIS

L. Punzi, M. Poswiadek, F. Oliviero, A. Lonigro, V. Modesti, R. Ramonda, S. Todesco

52-55

https://doi.org/10.4081/reumatismo.2007.1s.52

2223

PDF: 1375
MicroRNAs in autoimmune rheumatic diseases

M. Galeazzi, E. Balistreri, C. Giannitti, G.D. Sebastiani

7-17

16-03-2012

https://doi.org/10.4081/reumatismo.2012.7

934

PDF: 854
Metabolism plays the key roles in Th cells differentiation

A. Hosseinzadeh, S. Soukhtehzari, M. Ghaedi, R. Mansouri

176-182

31-12-2016

https://doi.org/10.4081/reumatismo.2016.919

1553

PDF: 1006
The pink side of spondyloarthritis: a narrative review across pathogenesis and clinical manifestations in women

C. Rizzo, L. La Barbera, A. D’Antonio, F. Camarda, P. Conigliaro, M.S. Chimenti, G. Guggino

11-09-2024

https://doi.org/10.4081/reumatismo.2024.1764

875

PDF: 301
Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis

A. Spadaro, A. Scarno, A. Carboni, F.M. Perrotta, C. Catalano, E. Lubrano, G. Valesini

134-137

24-07-2013

https://doi.org/10.4081/reumatismo.2013.134

2637

PDF: 745
CTLA4-Ig interferes and downregulates the proinflammatory activities of rheumatoid synovial macrophages in monoculture

R. Brizzolara, S. Soldano, P. Montagna, A. Sulli, B. Seriolo, B. Villaggio, P.F. Triolo, P. Clerico, L. Felli, L. Molfetta, M. Cutolo

80-85

https://doi.org/10.4081/reumatismo.2011.80

1434

PDF: 982
Wegener’s granulomatosis: an analysis of 50 patients

G. Di Comite, G. Bonavida, E. Bozzolo, S. Bozzolo, S. Bianchi, G. Ciboddo, M. Tresoldi, L. Praderio, M.G. Sabbadini

187-192

11-04-2005

https://doi.org/10.4081/reumatismo.2005.187

833

PDF: 1551
Successful treatment of refractory adult onset Still’s disease with rituximab

N. Belfeki, M. Smiti Khanfir, F. Said, A. Hamzaoui, T. Ben Salem, I. Ben Ghorbel, M. Lamloum, M.H. Houman

159-162

16-12-2016

https://doi.org/10.4081/reumatismo.2016.888

2471

PDF: 1226
Pain assessment strategies in patients with musculoskeletal conditions

F. Salaffi, A. Ciapetti, M. Carotti

216-229

28-09-2012

https://doi.org/10.4081/reumatismo.2012.216

2682

PDF: 3170
TNFa inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects

I. Cavazzana, F. Bobbio-Pallavicini, C. Bazzani, E. Bravi, S. Zingarelli, A. Ceribelli, R. Caporali, R. Cattaneo, F. Franceschini, C. Montecucco

275-282

https://doi.org/10.4081/reumatismo.2006.275

1051

PDF: 944
Methylenetetrahydrofolate reductase polymorphisms in methotrexate treatment of rheumatoid arthritis patients. Review of the literature and personal experience

M. Taraborelli, L. Andreoli, S. Archetti, M. Ferrari, R. Cattaneo, A. Tincani

98-106

https://doi.org/10.4081/reumatismo.2009.98

1255

PDF: 1149
Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide

M. Benucci, F. Li Gobbi, P. Panconesi, M. Manfredi, P. Sarzi-Puttini, F. Atzeni

90-94

27-05-2013

https://doi.org/10.4081/reumatismo.2013.90

2506

PDF: 904
Stress response system and personality in rheumatoid arthritis patients

C. Prete, F. Briano, C. Pizzorni, A. Sulli, M. Marcenaro, M. Cutolo

204-209

https://doi.org/10.4081/reumatismo.2001.204

1376

PDF: 891
Early rheumatoid arthritis: a prospective study on how to induce the remission

T. Ziglioli, C. Bazzani, M. Filippini, S. Zingarelli, A. Giugno, R. Gorla

131-135

https://doi.org/10.4081/reumatismo.2008.131

1030

PDF: 694
Multisystemic inflammatory syndrome related to COVID-19, with latent tuberculosis in bone marrow, and satisfactory response to tocilizumab, in a 7-year-old boy

Z. Morel, R. Suarez, E. Avalos, S. Velázquez, F. Martínez, V. Lezcano, N. Astigarraga, C. Ghezzi, S. Brizuela, G. Samudio

07-02-2022

https://doi.org/10.4081/reumatismo.2021.1448

6174

PDF: 735
Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis

A. Iagnocco, C. Perella, F. Ceccarelli, E. Tripodo, C. Alessandri, L. Magrini, G. Valesini

233-238

https://doi.org/10.4081/reumatismo.2006.233

1035

PDF: 1003
Effects of mannuronic acid (M2000) on gene expression profile of signal transducer and activator of transcription proteins (STATs) in rheumatoid arthritis patients

N.A.G. Gaafar, M. Aslani, Z. Aghazadeh, S.S. Mortazavi-Jahromi, A. Razavi, A. Mirshafiey

93-102

23-07-2020

https://doi.org/10.4081/reumatismo.2020.1235

930

PDF: 608
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis

M. Fabris, L. Quartuccio, S. Lombardi, M. Benucci, M. Manfredi, M. Saracco, F. Atzeni, P. Morassi, M.A. Cimmino, E. Pontarini, C. Fabro, R. Pellerito, P. Sarzi-Puttini, M. Cutolo, A. Carletto, L.M. Bambara, F. Fischetti, F. Curcio, E. Tonutti, S. De VIta

253-258

https://doi.org/10.4081/reumatismo.2010.253

2088

PDF: 840
Effects of estrogen peripheral metabolism in rheumatoid arthritis

S. Capellino, P. Montagna, B. Villaggio, M. Cutolo

78-82

https://doi.org/10.4081/reumatismo.2005.78

1361

PDF: 1894
Brachio-cervical inflammatory myopathy associated with systemic sclerosis. Case series and review of literature

C.S.R. Araujo, R. Miossi, F.H.C. De Souza, M.D. Costa, A.M.S. da Silva, E.D. Campos, E. Zanoteli, S.K. Shinjo

122-130

03-08-2021

https://doi.org/10.4081/reumatismo.2021.1397

3539

PDF: 926
Infliximab as successful treatment option in a case of adenosine deaminase 2 deficiency

M.B. Ates, S. Karup, S. Ugurlu

19-12-2023

https://doi.org/10.4081/reumatismo.2023.1543

1254

PDF: 377
Early rheumatoid arthritis

F. Atzeni, P. Sarzi-Puttini

100-117

https://doi.org/10.4081/reumatismo.2007.100

1495

PDF: 2099
The role of nailfold videocapillaroscopy in Raynaud’s phenomenon monitoring and early diagnosis of systemic sclerosis

M. Cutolo, C. Pizzorni, M. Meroni, G. Zampogna, C. Ferrone, E. Alessandri, F. Ravera, A. Sulli

237-247

https://doi.org/10.4081/reumatismo.2010.237

1616

PDF: 4827

1 - 50 of 102 items 1 2 3 > >>

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy